TNDM Q1 2023 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$1B

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$169M-3.7% YoY

Gross Profit

$83M48.9% margin

Operating Income

-$128M-75.5% margin

Net Income

-$124M-73.1% margin

EPS (Diluted)

$-1.92

QoQ Revenue Growth

-23.2%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$29M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$954M

Total Liabilities

$615M

Stockholders' Equity

$339M

Cash & Equivalents

$128M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$169M	$176M	-3.7%
Gross Profit	$83M	$91M	-9.0%
Operating Income	-$128M	-$15M	-733.3%
Net Income	-$124M	-$15M	-741.8%

Geographic Segments

UNITED STATES

$131M77%

Non-US

$38M23%